Chief medical officer, Global Drug Development, Samit Hirawat, M.D, recently reflected on the progress of the company’s R&D pipeline, the impact COVID-19 has had on clinical trials, and the completion of his first year! @bmsnews. http://ow.ly/ybUe50BsuCN

(Feed generated with FetchRSS)

(Feed generated with FetchRSS)